Physician profile
Mendy Tello
NPI 1598595613
$740.89
in general payments reported to CMS, 2019-2025
10 companies · $741 in 2025
The $741 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $218.38 | 2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $184.59 | 2025 | Entyvio, Eohilia |
| Pfizer INC. | $63.54 | 2025 | |
| Abbvie INC. | $57.89 | 2025 | |
| Novo Nordisk INC | $55.93 | 2025 | Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.34 | 2025 | Relistor |
| Celltrion USA INC. | $37.39 | 2025 | Vegzelma |
| Phathom Pharmaceuticals, INC. | $29.33 | 2025 | Voquezna |
| Biocon Biologics INC | $24.57 | 2025 | Yesintek |
| Genzyme Corporation | $21.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mendy Tello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.